Interferon sensitive recombinant poxvirus vaccine
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 3, 1995
Issued Date -
N/A
app pub date -
Dec 16, 1991
filing date -
Dec 24, 1981
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
What is described is a recombinant poxvirus, such as vaccinia virus, having enhanced sensitivity to interferon. In one embodiment, the recombinant poxvirus has an open reading frame conferring resistance to interferon deleted therefrom. In another embodiment, the recombinant poxvirus is modified to disrupt K3L gene expression. What is also described is a vaccine containing the recombinant poxvirus having enhanced sensitivity to interferon so that the vaccine has an increased level of safety compared to known recombinant poxvirus vaccines.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully